The EcoHealth Alliance’s grant has been reinstated, but the NIH’s conditions for reinstatement have not been met.
The National Institutes of Health (NIH) has reinstated a grant that had been terminated by President Donald Trump in...
A study conducted by the Cleveland Clinic suggests that taking additional booster shots may increase the risk of contracting COVID-19.
A study conducted on the effectiveness of the bivalent COVID-19 vaccine has surprised many at the...
A new study suggests that a high percentage of people who required help from a ventilator due to a COVID-19 infection also developed secondary bacterial pneumonia, which was responsible for a higher mortality rate than the COVID-19...
Margery Smelkinson, a research scientist at the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), said the US's failure to recognise natural immunity negatively affected the pandemic response.
The failure to recognize how...
The FDA has approved Vowst, which is the first oral biologic pill for fecal microbiota containing human feces.
Patients needing a fecal microbiota transplant for recurrent Clostridioides difficile (C. diff) infections now have the...
The NIH has restarted the 'Bat Virus Grant' to Peter Daszak and EcoHealth Alliance, a nonprofit research organization in New York City, which is a new 4-year grant that represents a stripped-down version of the original grant.
According to research commissioned by the federal government and conducted by Ekos Research Associates, parents are more likely to question routine childhood vaccinations post-COVID.
Canadian parents have become more likely to question routine childhood...
Eight years ago, Beverly Hills urologist James Elist invented the Penuma, a new form of cosmetic surgery to enhance men’s penises. For $16,000, Dr. Elist makes an incision just above a patient’s penis and inserts the Penuma, a sheath of silicone, into the shaft, adding anywhere from one to two inches in length and up to two and a half inches in girth.
At least 500 Australians have already joined a “landmark” COVID-19 vaccine injury class action lawsuit filed this week against the Australian government and the medicines regulator seeks redress for those allegedly injured or left bereaved by the COVID-19 vaccines.
Tirzepatide, an Eli Lilly and Co. obesity drug approved to treat type 2 diabetes, is poised to blow up the weight loss industry.
